Skip to main navigation Skip to search Skip to main content

Assessing the tumor-reactivity of driver mutation specific TCRs and the TIL-derived TCR repertoire in cancer patients (pancreatic cancer)

Project Details

Short titleAssessing the tumor-reactivity of driver mutation specific TCRs and the TIL-derived TCR repertoire in cancer patients (pancreatic cancer)
StatusActive
Effective start/end date27/11/25 → 26/11/27

Funding

  • Astra Zeneca Uk Limited